Intestinal smooth muscle activity

Intestinal smooth muscle activity refers to the coordinated contraction and relaxation of the smooth muscle layers within the gastrointestinal tract, which is fundamental for peristalsis, mixing, and the propulsion of luminal contents (StatPearls, 2023). It is not a single molecular target or receptor but rather a complex physiological process or phenotypic endpoint regulated by the enteric nervous system, interstitial cells of Cajal, and various hormonal signals. Pharmacological agents typically modulate this activity by targeting specific receptors such as muscarinic M3, 5-HT4, 5-HT3, or mu-opioid receptors to treat conditions like gastroparesis, chronic constipation, or diarrhea (PubMed, 2022). In drug development, this activity is frequently used as a functional readout in organ bath experiments or in vivo transit studies to evaluate the prokinetic or antispasmodic potential of new compounds. Because it represents a global physiological state, dysregulation of intestinal smooth muscle activity is a hallmark of many gastrointestinal motility disorders and is a significant consideration in assessing the safety profile of drugs across various therapeutic classes.

Other names

Gastrointestinal motilityIntestinal motilityEnteric smooth muscle contractionPeristalsisGI transit

Regulation of intestinal transit via the modulation of neurotransmitter release (e.g., acetylcholine, serotonin, dopamine) or through direct agonism/antagonism of G protein-coupled receptors (GPCRs) and ion channels located on smooth muscle cells or enteric neurons.